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Eosinophilic angiocentric fibrosis (EAF) is an uncommon inflammatory disease that develops from the respiratory
organs and affects them. Almost all reports about EAF describe lesions affecting the upper respiratory tract. We
present the first case of EAF of the lung treated by surgical excision. A 69-year-old female consulted our hospital
following the detection of an abnormal chest shadow with chronic cough. Chest computed tomography showed
a pulmonary growing mass in the right hilar area, which corresponded to an enhanced accumulation on positron
emission tomography. We doubted a pulmonary malignant tumor and performed a right upper lobectomy.
Pathological and other clinical presentations revealed EAF of the lung without coexisting systemic diseases. The
patient had an uncomplicated postoperative course, and the presenting cough had improved. EAF can involve
the lung and cause symptomatic airway obstruction. For a hilar region mass with imaging characteristics similar
to those of lung cancer, a differential diagnosis must be considered.
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Eosinophilic angiocentric fibrosis (EAF) is a rare dis-
order typically involving the upper respiratory tract,
although it may very rarely affect the lower respiratory
tract. Furthermore, EAF lacks an established treatment.
Almost all reported cases were surgically treated and
pulmonary lesions have never been reported. EAF is con-
sidered a progressive benign disorder, and the diagnosis is
chiefly based on histopathological findings [1] more spe-
cifically the presence of an inflammatory infiltrate with
numerous eosinophils and fibro-inflammatory lesions.
The perivascular fibrotic changes are characterized by a
whorled, “onion skin”-type pattern [1, 2].
The etiology of this progressive disorder is unknown
[3]. It has been suggested that several conditions act as
predisposing factors, but the evidence in this regard is
lacking. We present the first case of EAF manifesting as
a pulmonary lesion.* Correspondence: kokamoto-sig@umin.ac.jp
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A 69-year-old woman consulted our hospital following
the detection of an abnormal chest shadow. She had a
history of chronic cough despite having never smoked.
She did not have a history of trauma or prior thoracic
surgery. Laboratory examinations did not reveal abnor-
malities that would have indicated organ disorder or
active inflammatory processes. Using chest computed
tomography (CT), we identified a localized pulmonary
mass with a diameter of 30 mm in the right lung hilar
region. Retrospectively, the mass was visibly larger com-
pared with that on a CT image obtained 3 years earlier
(Fig. 1a, b). On 18F-fluoro-deoxy-glucose positron emis-
sion tomography (FDG-PET), the mass showed an
enhanced accumulation of contrast (Fig. 1c). To estab-
lish a tissue diagnosis, we performed a bronchoscopic
examination. Slight narrowing of the superior bronchial
ostia by extrinsic displacement was observed (Fig. 1d).
Specimens obtained by bronchial mucosal and transbron-
chial lung biopsy indicated only normal tissue. However,
we were concerned about the possibility of primary lung
cancer and performed video-assisted thoracic surgery with
right upper lobectomy. The tumor surface was well
circumscribed and farm ash-gray. There was no gross
invasion into the pulmonary artery and superior bronchus.article distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 a Original CT scan obtained 3 years ago showed a pulmonary nodule in the upper area of the right lung. b CT scan on admission showed
an enlarged mass. c FDG-PET indicated high accumulation in the mass region (SUV max = 6.5). d Bronchoscopic examination revealed narrowing
of the superior bronchial ostia. The bronchial mucosa was macroscopically normal
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this localized pulmonary tumor was benign. Having
resected the superior bronchus, we pathologically con-
firmed that the bronchial mucosa was normal. The
patient had an uncomplicated postoperative course and
was discharged 1 week later.
Histopathological analysis revealed a dense inflamma-
tory infiltrate with numerous eosinophils and perivas-
cular fibrosis but without signs of necrotizing vasculitis
or giant cell formation. The fibro-inflammatory lesions
displayed a characteristic whorled, onion skin-like fibrotic
pattern, which is a specific finding in EAF. Immunostain-
ing showed a large amount of cells (400 cells per high-
power field) that were positive for immunoglobulin G4
(IgG4) (Fig. 2).
We suspected the concurrent presence of a systemic
disease, such as IgG4-related disorders and granuloma-
tosis with polyangitis (GPA), and repeated blood tests
using preoperative preserved blood. Serological assays
for IgG, IgE, IgG4, cytoplasmic anti-neutrophil antibody
(c-ANCA), as well as urinalysis, were all negative. The
only positive finding was the presence of perinuclearanti-neutrophil antibodies (p-ANCA, 19.1 U/mL).
However, there were no other clinical findings, such as
retroperitoneal fibrosis or active inflammation, which
would have been consistent with the diagnostic criteria
for these diseases. Finally, we diagnosed EAF of the
lung. The p-ANCA levels decreased postoperatively
(12.1 U/mL), and the presenting cough had improved.
We recommended regular follow-up, and the patient
has so far been recurrence-free.
Discussion
EAF is a rare disorder that involves the upper respiratory
tract, which is diagnosed on the basis of the characteristic
pathological findings, as previously mentioned [1–3]. The
histopathological diagnosis takes two possible disease pro-
gression states into consideration: an inflammatory state
and a fibrotic state [4, 5]. It is considered that the disease
progresses from the early-state inflammatory lesion, with
numerous eosinophils and perivascular onion skin fibros-
ing to a late state characterized by subsequent perivascular
fibrosis formation and decreased inflammatory infiltration.
In our case, the resected specimen contained these
Fig. 2 Pathological analysis showed a a dense bronchocentric inflammatory infiltrate with numerous inflammatory cells and perivascular fibrosis.
b Fibro-inflammatory lesion (perivascular fibrosis) surrounding the vessel in a whorled pattern. Numerous eosinophils infiltrate the lesion. c A fibrotic
nodule with the “onion-skin” fibrosis pattern that is pathognomonic for eosinophilic angiocentric fibrosis. d Immunohistochemical staining for IgG4
revealed a large number of IgG4-positive cells (400 cells per high-power field)
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The enhanced accumulation on FDG-PET reflected the
inflammatory cell infiltration and indicated a high-activity
lesion. EAF of the lung should be considered in the differ-
ential diagnosis of a hilar mass lesion with abnormal accu-
mulation that mimics lung cancer.
The etiology of EAF is unknown; atopy, trauma, sur-
gery, and immunologic disease have been proposed as
predisposing factors, but none of these is supported by
evidence [6, 7]. Deshpande et al. reported five cases of
EAF and concluded that EAF belongs to a spectrum of
IgG4-related disorders [4]. In their cases, numerous
IgG4-positive plasma cells have been observed in EAF
biopsy samples, together with elevated serum IgG4 levels
[8]. Although our case showed similar pathological find-
ings, other laboratory results did not concur. We did not
reach the definite the diagnosis for IgG4-related disease.
The differential diagnosis of pulmonary EAF includes
GPA and eosinophilic GPA (EGPA) [3, 9], both systemic
diseases with lung involvement. The most important
histopathological distinguishing features are necrosis
and vasculitis, which are not observed in EAF in our
case. In addition, our patient lacked the diagnostic clin-
ical findings associated with GPA and EGPA [10, 11].
The only positive serum assay was p-ANCA, which are
the autoantibodies observed characteristically in EGPA.
However, they are observed only in half of the EGPAcases, and the criteria proposed by the American College
of Rheumatology do not include p-ANCA [11]. Our
patient had not any clinically associated presentation.
Consequently, we did not reach the definite diagnosis
for these diseases.
While EAF is a benign disorder that involves the upper
respiratory tract and leads to airway obstruction, the
obstructive symptoms develop gradually because EAF is
slow growing and progressive. Kim et al. reported a case
of EAF that occurred in the bronchial lumen of a patient
who presented with respiratory distress [5]. Similarly, in
our case, chronic cough appeared as a local manifest-
ation and disappeared after surgical treatment. If bron-
chial narrowing had progressed, disorders such as
obstructive pneumonia would have developed. The
medical treatment of EAF is not established. Therefore,
surgical treatment for symptomatic relief was required
in most of the reported cases. Whenever surgical resec-
tion is deemed feasible, it is desirable to intervene before
the obstruction becomes severe. Among the cases where
surgical excision was performed, one recurrence was
described following a non-total resection [3]. Even in the
case of a pulmonary lesion, a total resection may be
required, and we therefore insist on the confirmation of
the surgical margin by intraoperative rapid diagnosis.
In our case, EAF was not associated with a co-existing
systemic disease. As previously described, EAF is an
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is not known if EAF is a partial manifestation of a
systemic illness, which highlights the importance of
performing an adequate evaluation. As reported by
Rimmer et al. [12], the possibility of advancing toward
the development of these diseases is an important con-
cern. Careful follow-up after surgery is also important.
Conclusions
We report a surgical case of EAF of the lung that mim-
icked lung cancer. EAF is an unidentified benign disorder,
but its growth can adversely affect organ function. In the
case of a pulmonary lesion, it is desirable to completely
remove it surgically before the development of airway ob-
struction. In addition, it is necessary to explore the possi-
bility of an underlying systemic disease before making the
diagnosis.
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